When choosing or negotiating a new drug price, there are a number of variables to consider
It’s not just a matter of figuring out how much payers are willing to reimburse, but also how higher prices lead to more restrictions, which affect physicians’ willingness to prescribe.
But where, exactly, are those thresholds? How do you make sure you’re taking everything into account when developing your price and market access strategy, so you aren’t surprised by unforeseen variables?
That’s what we’re here to help with.